| Terminated | Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer SBRT, Borderline Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer | Phase 2 | 2021-05-07 |
| Terminated | Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC SBRT, NSCLC, Non-metastatic | Phase 1 / Phase 2 | 2020-10-18 |
| Terminated | A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Covid19, SARS-CoV-2 Infection | Phase 2 | 2020-09-09 |
| Completed | Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer Head and Neck Cancer, Oral Mucositis | Phase 2 | 2020-06-30 |
| Terminated | Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung C Esophagitis | Phase 2 | 2019-12-19 |
| Completed | Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics, Safety and Tolerability of GC4419 Renal Impairment | Phase 1 | 2019-04-04 |
| Completed | A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutas Healthy | Phase 1 | 2019-03-19 |
| Completed | Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Healthy | Phase 1 | 2019-02-10 |
| Completed | A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) a Healthy Volunteers | Phase 1 | 2018-10-16 |
| Completed | ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Canc Oral Mucositis | Phase 3 | 2018-10-03 |
| Completed | Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancre Pancreatic Cancer, Stereotactic Body Radiation Therapy | Phase 1 / Phase 2 | 2018-02-12 |
| Completed | A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Healthy Volunteers, Healthy | Phase 1 | 2017-09-25 |
| Completed | A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose Healthy Volunteers, Healthy | Phase 1 | 2017-08-18 |
| Completed | A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subj Healthy Volunteers, Healthy | Phase 1 | 2017-08-14 |
| Completed | A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers Healthy Volunteer | Phase 1 | 2016-07-26 |
| Completed | A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer Radiation Induced Oral Mucositis | Phase 2 | 2015-10-12 |
| Completed | A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the H Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx | Phase 1 | 2013-08-01 |